NASDAQ:IDYA

Ideaya Biosciences Stock Earnings Reports

etoro logo Buy IDYA
*Your capital is at risk
$33.34
+1.20 (+3.73%)
At Close: Nov 17, 2025

IDEAYA Biosciences Earnings Calls

Sep 30, 2025
$1.33 (244.90%)
Release date Nov 04, 2025
EPS estimate -$0.92
EPS actual $1.33
EPS Surprise 244.90%
Revenue estimate 5.962M
Revenue actual 207.834M
Revenue Surprise 3,385.91%
Jun 30, 2025
-$0.88 (-3.53%)
Release date Aug 05, 2025
EPS estimate -$0.85
EPS actual -$0.88
EPS Surprise -3.53%
Revenue estimate 2M
Revenue actual -
Mar 31, 2025
-$0.82 (-9.33%)
Release date May 06, 2025
EPS estimate -$0.750
EPS actual -$0.82
EPS Surprise -9.33%
Revenue estimate 2.396M
Revenue actual -
Dec 31, 2024
-$1.49 (-122.39%)
Release date Feb 13, 2025
EPS estimate -$0.670
EPS actual -$1.49
EPS Surprise -122.39%
Revenue estimate 2.495M
Revenue actual 7M
Revenue Surprise 180.56%

Last 4 Quarters for IDEAYA Biosciences

Below you can see how IDYA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Missed
Release date Feb 13, 2025
Price on release $20.76
EPS estimate -$0.670
EPS actual -$1.49
EPS surprise -122.39%
Date Price
Feb 07, 2025 $23.00
Feb 10, 2025 $22.42
Feb 11, 2025 $21.38
Feb 12, 2025 $21.95
Feb 13, 2025 $20.76
Feb 14, 2025 $21.00
Feb 18, 2025 $20.44
Feb 19, 2025 $20.66
Feb 20, 2025 $21.73
4 days before -9.74%
4 days after 4.67%
On release day 1.16%
Change in period -5.52%
Mar 31, 2025 Missed
Release date May 06, 2025
Price on release $17.75
EPS estimate -$0.750
EPS actual -$0.82
EPS surprise -9.33%
Date Price
Apr 30, 2025 $20.13
May 01, 2025 $20.47
May 02, 2025 $20.93
May 05, 2025 $20.47
May 06, 2025 $17.75
May 07, 2025 $17.83
May 08, 2025 $18.18
May 09, 2025 $17.42
May 12, 2025 $18.35
4 days before -11.82%
4 days after 3.38%
On release day 0.451%
Change in period -8.84%
Jun 30, 2025 Missed
Release date Aug 05, 2025
Price on release $24.12
EPS estimate -$0.85
EPS actual -$0.88
EPS surprise -3.53%
Date Price
Jul 30, 2025 $25.35
Jul 31, 2025 $24.35
Aug 01, 2025 $24.27
Aug 04, 2025 $25.00
Aug 05, 2025 $24.12
Aug 06, 2025 $23.63
Aug 07, 2025 $22.41
Aug 08, 2025 $23.10
Aug 11, 2025 $22.84
4 days before -4.85%
4 days after -5.31%
On release day -2.03%
Change in period -9.90%
Sep 30, 2025 Beat
Release date Nov 04, 2025
Price on release $30.48
EPS estimate -$0.92
EPS actual $1.33
EPS surprise 244.90%
Date Price
Oct 29, 2025 $32.18
Oct 30, 2025 $31.60
Oct 31, 2025 $31.86
Nov 03, 2025 $31.36
Nov 04, 2025 $30.48
Nov 05, 2025 $29.66
Nov 06, 2025 $29.85
Nov 07, 2025 $30.24
Nov 10, 2025 $30.89
4 days before -5.28%
4 days after 1.35%
On release day -2.69%
Change in period -4.01%

IDEAYA Biosciences Earnings History

Earnings Calendar

FAQ

When is the earnings report for IDYA?
IDEAYA Biosciences Inc. (IDYA) has scheduled its earnings report for Feb 12, 2026 before the markets open.

What is the IDYA price-to-earnings (P/E) ratio?
IDYA P/E ratio as of Nov 17, 2025 (TTM) is -8.59.

What is the IDYA EPS forecast?
The forecasted EPS (Earnings Per Share) for IDEAYA Biosciences Inc. (IDYA) for the first fiscal quarter 2025 is -$1.03.

What are IDEAYA Biosciences Inc.'s retained earnings?
On its balance sheet, IDEAYA Biosciences Inc. reported retained earnings of $207.83 million for the latest quarter ending Sep 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT IDEAYA BIOSCIENCES INC.
IDEAYA Biosciences
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE